Reducing inflammation in COPD: the evidence builds
- PMID: 17965073
- PMCID: PMC2117134
- DOI: 10.1136/thx.2007.082677
Reducing inflammation in COPD: the evidence builds
Abstract
Anti‐inflammatory activity of a combination of an inhaled steroid and a long‐acting β2 agonist in COPD
Comment on
-
Effect of salmeterol/fluticasone propionate on airway inflammation in COPD: a randomised controlled trial.Thorax. 2007 Nov;62(11):938-43. doi: 10.1136/thx.2006.071068. Epub 2007 Jun 8. Thorax. 2007. PMID: 17557771 Free PMC article. Clinical Trial.
References
-
- Global Initiative for Chronic Obstructive Lung Disease Global strategy for the diagnosis, management and prevention of chronic obstructive lung disease. Bethesda: National Heart Lung and Blood Institute, 2006
-
- Hogg J C, Chu F, Utokaparch S.et al The nature of small‐airways obstruction in chronic obstructive pulmonary disease. N Engl J Med 20043502645–2653. - PubMed
-
- O'Shaughnessy T, Ansari T W, Barnes N C.et al Inflammation in bronchial biopsies of subjects with chronic bronchitits: inverse relationship of CD8+ T lymphocytes with FEV1. Am J Respir Crit Care Med 1997155852–857. - PubMed
-
- Saetta M, Baraldo S, Corbino L.et al CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999160711–717. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical